306626
Statewide collaborative to reduce early elective deliveries
Methods: Using 2010-2012 birth certificate data and a nationally-vetted algorithm based on the Joint Commission measure, hospital-specific rates of EED were compared overall, within regional perinatal networks and hospital level, and over time. Letters were sent to each hospital with the data and QI resources. Hospitals were encouraged to develop a hard stop policy and to work through the perinatal networks to address hospital and community reasons for EED.
Results: The rate of EED in Illinois declined from 29.6% in 2010 to 25.0% in 2012. Rates were higher among non-Hispanic white women, women who had insurance, and hospitals located in rural counties. Rates did not differ according to level of care, but did vary by perinatal network from 13.7% to 32.4%.
Conclusions: Through the perinatal networks and the CoIIN, Illinois has begun efforts to improve data quality on the birth certificate, to explore adding clinical and social determinant items to the birth certificate and to implement linkage with hospital discharge data. Data resources and partnerships established for this project can be used for ongoing efforts to improve maternal healthcare and reduce infant mortality.
Learning Areas:
EpidemiologyPublic health or related laws, regulations, standards, or guidelines
Learning Objectives:
Identify strengths of statewide public-private partnership to improve maternal health
Describe early elective delivery risk factors and outcomes
Assess innovations to reduce EED at the state level
Keyword(s): Public/Private Partnerships, MCH Epidemiology
Qualified on the content I am responsible for because: I have been a principal or co principal investigator on many federally grants dealing with MCH issues. I am currently the Chief for the division of patient safety and quality at the Illinois Dept. of Public Health and Early Elective Delivery is a safety issue.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.